|
|
Volumn 39, Issue 7, 1999, Pages 675-684
|
|
Pharmacokinetics and pharmacodynamics of sibrafiban, an orally administered IIb/IIIa antagonist, in patients with acute coronary syndrome.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMIDINE;
ANTITHROMBOCYTIC AGENT;
FIBRINOGEN RECEPTOR;
HETEROCYCLIC COMPOUND;
OXIME;
PIPERIDINE DERIVATIVE;
PRODRUG;
RO 44 3888;
RO 44-3888;
RO 48 3656;
RO 48-3656;
SIBRAFIBAN;
ACUTE DISEASE;
ADULT;
AGE;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD;
BODY WEIGHT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG ANTAGONISM;
FEMALE;
GLOMERULUS FILTRATION RATE;
HUMAN;
MALE;
METABOLIC CLEARANCE RATE;
METABOLISM;
MIDDLE AGED;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
SYNDROME;
URINE;
ACUTE DISEASE;
ADMINISTRATION, ORAL;
ADULT;
AGE FACTORS;
AGED;
AGED, 80 AND OVER;
AMIDINES;
AREA UNDER CURVE;
BODY WEIGHT;
CORONARY DISEASE;
DOUBLE-BLIND METHOD;
FEMALE;
GLOMERULAR FILTRATION RATE;
HETEROCYCLIC COMPOUNDS;
HUMANS;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
OXIMES;
PIPERIDINES;
PLATELET AGGREGATION INHIBITORS;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PRODRUGS;
SYNDROME;
|
|
EID: 0033162553
PISSN: 00912700
EISSN: None
Source Type: Journal
DOI: 10.1177/00912709922008317 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
